{"store":{"baseInfo":{"podcastTitle":"CaReSyAn Project","slug":"caresyan","podcastDescription":"European Commission project H2020-MSCA-ITN-2017 CaReSyAn: Combatting the CardioRenal Syndrome.","podcastLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/4013496/Logo.jpg","podcastShareLogo":null,"podcastUrl":"https://caresyan.podbean.com","podcastCanSearched":false,"feedUrl":"https://feed.podbean.com/caresyan/feed.xml","theme":"elegant","podcastDeepLink":"https://www.podbean.com/pu/pbblog-akvur-3d3db8","removePodbeanBranding":"no","brandingLogo":null,"timeZone":{"timeZoneId":31,"gmtAdjustment":"GMT+01:00","useDaylightTime":1,"value":1,"text":"(GMT+01:00) Amsterdam, Berlin, Bern, Rome, Stockholm, Vienna","daylightStartTime":"Last Sunday of March +1 Hours","daylightEndTime":"Last Sunday Of October +1 Hours","timezone":"Europe/London"},"podcastDownloads":null,"totalEpisodes":10,"showComments":true,"iOSAppDownloadLink":null,"customizeCssUrl":null,"androidAppDownloadLink":null,"showPostShare":true,"showLike":true,"author":"caresyan","engagementStatsBaseUrl":null,"shareEmbedLink":"https://admin5.podbean.com/embed.html?id=pbblog-akvur-3d3db8-playlist","language":"en","sensitivitySessionExpireTime":3600,"podcastApps":[{"name":"Podbean App","link":"https://r4j68.app.goo.gl/?link=https%3A%2F%2Fcaresyan.podbean.com%3Faction%3DopenPodcast%26podcastId%3Dpbblog4013496%26podcastIdTag%3Dakvur&dfl=https%3A%2F%2Fcaresyan.podbean.com&utm_campaign=pb_web&utm_source=podbean_web&utm_medium=dlink&imv=670&amv=530&isi=973361050&ibi=com.podbean.app.podcast&ipbi=com.podbean.app.podcast&apn=com.podbean.app.podcast","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/podbean-app.png","title":null}],"components":{"base":[{"id":"MainStyle","val":"light"},{"id":"Font","val":"Avenir"},{"id":"SecondaryFont","val":"Avenir"},{"id":"PlayerColor","val":"#8fc31f"},{"id":"PlayerStyle","val":"player1"},{"id":"PlayerWave","val":"show"},{"id":"Favicon","val":null},{"id":"CookiesNotice","val":"hide"},{"id":"CookiesNoticeContent","val":"

Cookies Notice

This website uses cookies to improve your experience while you navigate through the website. By using our website you agree to our use of cookies.

"}],"home-header":[{"id":"HomeHeaderTextColor","val":"#000000"},{"id":"HomeHeaderBackgroundColor","val":"#ffffff"}],"page-header":[{"id":"PageHeaderTextColor","val":"#ffffff"},{"id":"PageHeaderBackgroundColor","val":"#868686"}],"episode-list":[{"id":"EpisodeListType","val":"simple-list"},{"id":"EpisodesPerPage","val":10},{"id":"EpisodeStats","val":"show"}],"navigation":[{"id":"NavigationFontColor","val":"#000000"},{"id":"NavigationBackgroundColor","val":"#e9e9e9"},{"id":"NavigationSearch","val":"show"},{"id":"NavigationLinks","val":[{"id":"Home","type":"Link","value":"/","text":"Home","subitems":[]},{"id":"Subscribe","type":"Link","value":"https://www.podbean.com/site/podcatcher/index/blog/LM0Y0WFJrcwN","text":"Subscribe","subitems":[]},{"id":"Profile","type":"Link","value":"https://www.podbean.com/user-g9VPMLCk8uG0","text":"Profile","subitems":[]}]}],"footer":[{"id":"FooterType","val":"Footer2"},{"id":"FooterFontColor","val":"#ffffff"},{"id":"FooterBackgroundColor","val":"#000000"},{"id":"FooterCopyright","val":"Copyright 2018 All rights reserved."},{"id":"SocialMediaLinks","val":{"facebook_username":"","twitter_username":"","instagram_username":"","youtube_username":"","linkedin_username":""}}],"customize-container1":[],"customize-container2":[]},"allLinks":[],"mainStylesDefaultSettings":null,"defaultCustomizeComponents":null,"scripts":["https://www.googletagmanager.com/gtag/js?id=G-TP93LLY3WQ","\n window.dataLayer = window.dataLayer || [];\n function gtag(){dataLayer.push(arguments);}\n gtag('js', new Date());\n\n gtag('config', 'G-TP93LLY3WQ',{'allow_enhanced_conversions':true});\n"],"metas":null,"appConfig":{"package":"com.podbean.app.podcast","app_store_id":973361050,"app_name":"Podbean","scheme":"podbean"},"customizeCss":null,"canEditCss":null,"enableJsCodeInCustomizeContent":false,"enabledIframeCodeInCustomizeContent":false,"sectionMaxCount":10,"enableEditorLink":false,"enableEditCookiesNotice":false,"siteRedirectToFeed":false,"podcatcherRssUrl":null,"showFeed":true,"showTopBar":true,"enableWebSiteLike":true,"organizationName":null,"organizationPageLink":null},"backToListUrl":"/","tinymceLoaded":false,"listEpisodes":[],"userLikedEpisodes":[],"topBarIframeLoaded":false,"listTotalCount":0,"listTotalPage":0,"listPage":0,"listType":"all","listValue":"","listName":"","pageLoading":false,"apiBaseUrl":"https://caresyan.podbean.com","apiCommonParams":{"t":"67ee1163","clientSignature":"3b0e5a23e31b12a5667e728e68d0029f","u":null,"customizing":null},"apiCommonHeaders":{},"comments":[],"commentsTotalCount":0,"commentsTotalPage":0,"commentsPage":1,"commentEpisodeId":"pb10628762-3vxhg","episode":{"id":"pb10628762","idTag":"3vxhg","title":"The role of novel biomarkers","logo":"https://pbcdn1.podbean.com/imglogo/image-logo/4013496/Logo_300x300.jpg","shareLogo":null,"largeLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/4013496/Logo.jpg","previewContent":null,"content":"

Today, Ana Amaya, a PhD student at INSERM institute in Toulouse, France will talk about the identification of novel biomarkers in Chronic Kidney Disease and their role in the development of the Cardiorenal Syndrome.

","publishTimestamp":1545129003,"duration":190,"mediaUrl":"https://mcdn.podbean.com/mf/web/i4pbmd/ESR6_Podcast-AnaAmaya_INSERM.mp3","mediaType":"audio/mpeg","shareLink":"https://admin5.podbean.com/embed.html?id=pb-3vxhg-a22e9a","likedCount":0,"deepLink":"https://www.podbean.com/ew/pb-3vxhg-a22e9a","transcriptUrl":null,"permalink":"/e/the-role-of-novel-biomarkers/","downloadLink":"https://www.podbean.com/site/EpisodeDownload/PBA22E9A3VXHG","fallbackResource":null,"fallbackResourceMimetype":null,"downloadCount":19,"status":"publish","hasMoreContent":false,"chaptersUrl":null,"explicit":false},"episodeShareLink":null,"deepLink":"https://www.podbean.com/ew/pb-3vxhg-a22e9a","playlist":{"episodes":[],"current":0,"start":0,"stop":0,"playing":true,"playerLoading":true,"playbackRate":1,"playbackRateIndex":1},"toasts":[],"confirm":null,"customizeEditorFormZIndex":999,"lastRequestTime":null,"validateChangesOnBeforeunload":true,"windowWidth":1000,"VITE_FS1_CDN_URL_PREFIX":"https://pbcdn1.podbean.com/fs1","reloadStats":false},"episode":{"id":"pb10628762","idTag":"3vxhg","title":"The role of novel biomarkers","logo":"https://pbcdn1.podbean.com/imglogo/image-logo/4013496/Logo_300x300.jpg","shareLogo":null,"largeLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/4013496/Logo.jpg","previewContent":null,"content":"

The role of novel biomarkers

Comments (0)